San Francisco, CA, June 5, 2019, 2019 – ProSomnus Sleep Technologies is pleased to announce the official launch of the ProSomnus [PH] Precision Herbst-style Sleep Apnea Device. The only precision Oral Appliance Therapy medical device for the treatment of Medicare patients with OSA, the device is engineered for comfort, ease of use and effectiveness.
Patented and FDA cleared, ProSomnus [PH] received Medicare verification earlier this year and has been available on a limited basis. In a follow up survey of nine leading Dental Sleep Medicine clinicians involving 75 patients 96% of survey participants would prescribe [PH] again, 82% found the overall size and profile to be preferable to other device options, and 99% of survey participants would recommend [PH] to a colleague.
“Leading Dental Sleep Medicine practitioners challenged ProSomnus to engineer a better device for Medicare patients and for patients who require treatment with a Herbst-style device,” noted Len Liptak, CEO of ProSomnus. “Though Medicare coding can constrain innovation, the team did an exceptional job accepting the challenge. ProSomnus [PH] has precision features that make the device smaller, stronger, more comfortable, and easy to use. ProSomnus [PH] also leverages technologies from our other OSA devices that have been scientifically proven to minimize the risk of side effects such as unwanted tooth movement.”
ProSomnus Sleep Technologies will be showcasing the new ProSomnus [PH] device at the upcoming AADSM and AASM Sleep conferences in San Antonio, Texas, June 7-9 and June 8-12, respectively.